Ronald C. Montelaro - Publications

Affiliations: 
University of Pittsburgh, Pittsburgh, PA, United States 
Area:
Microbiology Biology

218 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2022 Huang DB, Brothers KM, Mandell JB, Taguchi M, Alexander PG, Parker DM, Shinabarger D, Pillar C, Morrissey I, Hawser S, Ghahramani P, Dobbins D, Pachuda N, Montelaro R, Steckbeck JD, et al. Engineered peptide PLG0206 overcomes limitations of a challenging antimicrobial drug class. Plos One. 17: e0274815. PMID 36112657 DOI: 10.1371/journal.pone.0274815  0.732
2020 Beumera JH, Guo J, Ray EC, Scemama J, Parise RA, Deslouches B, Steckbeck JD, Montelaro RC, Eiseman JL. Mass Balance Study of the Engineered Cationic Antimicrobial Peptide, WLBU2, Following a Single Intravenous Dose of 14C-WLBU2 in Mice. Current Clinical Pharmacology. PMID 32778037 DOI: 10.2174/1574884715666200810094201  0.795
2020 Deslouches B, Montelaro RC, Urish KL, Di YP. Engineered Cationic Antimicrobial Peptides (eCAPs) to Combat Multidrug-Resistant Bacteria. Pharmaceutics. 12. PMID 32486228 DOI: 10.3390/Pharmaceutics12060501  0.732
2020 Di YP, Lin Q, Chen C, Montelaro RC, Doi Y, Deslouches B. Enhanced therapeutic index of an antimicrobial peptide in mice by increasing safety and activity against multidrug-resistant bacteria. Science Advances. 6: eaay6817. PMID 32426473 DOI: 10.1126/Sciadv.Aay6817  0.739
2019 Kumagai A, Dupuy FG, Arsov Z, Elhady Y, Moody D, Ernst RK, Deslouches B, Montelaro RC, Peter Di Y, Tristram-Nagle S. Elastic behavior of model membranes with antimicrobial peptides depends on lipid specificity and d-enantiomers. Soft Matter. PMID 30702120 DOI: 10.1039/C8Sm02180E  0.707
2018 Lin Q, Deslouches B, Montelaro RC, Di YP. Prevention of ESKAPE pathogen biofilm formation by antimicrobial peptides WLBU2 and LL37. International Journal of Antimicrobial Agents. PMID 29753132 DOI: 10.1016/J.Ijantimicag.2018.04.019  0.732
2017 Mandell JB, Deslouches B, Montelaro RC, Shanks RMQ, Doi Y, Urish KL. Elimination of Antibiotic Resistant Surgical Implant Biofilms Using an Engineered Cationic Amphipathic Peptide WLBU2. Scientific Reports. 7: 18098. PMID 29273750 DOI: 10.1038/S41598-017-17780-6  0.705
2017 Chen C, Deslouches B, Montelaro RC, Di YP. Enhanced efficacy of the engineered antimicrobial peptide WLBU2 via direct airway delivery in a murine model of P. aeruginosa pneumonia. Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases. PMID 28882728 DOI: 10.1016/j.cmi.2017.08.029  0.733
2017 Hasek ML, Steckbeck JD, Deslouches B, Craigo JK, Montelaro RC. Engineered Cationic Antimicrobial Peptides Containing Cholesterol Interacting Motifs to Target Viral Envelopes Journal of Antivirals & Antiretrovirals. 9. DOI: 10.4172/1948-5964.1000158  0.821
2016 Melvin JA, Montelaro RC, Bomberger JM. Clinical potential of engineered cationic antimicrobial peptides against drug resistant biofilms. Expert Review of Anti-Infective Therapy. PMID 27626708 DOI: 10.1080/14787210.2016.1236687  0.359
2016 Melvin JA, Lashua LP, Kiedrowski MR, Yang G, Deslouches B, Montelaro RC, Bomberger JM. Simultaneous Antibiofilm and Antiviral Activities of an Engineered Antimicrobial Peptide during Virus-Bacterium Coinfection. Msphere. 1. PMID 27303744 DOI: 10.1128/mSphere.00083-16  0.74
2016 Lashua LP, Melvin JA, Deslouches B, Pilewski JM, Montelaro RC, Bomberger JM. Engineered cationic antimicrobial peptide (eCAP) prevents Pseudomonas aeruginosa biofilm growth on airway epithelial cells. The Journal of Antimicrobial Chemotherapy. PMID 27231279 DOI: 10.1093/Jac/Dkw143  0.732
2016 Gearhart TL, Montelaro RC, Schurdak ME, Pilcher CD, Rinaldo CR, Kodadek T, Park Y, Islam K, Yurko R, Marques ET, Burke DS. Selection of a potential diagnostic biomarker for HIV infection from a random library of non-biological synthetic peptoid oligomers. Journal of Immunological Methods. PMID 27182050 DOI: 10.1016/J.Jim.2016.05.001  0.354
2016 Deslouches B, Hasek ML, Craigo JK, Steckbeck JD, Montelaro RC. Comparative functional properties of engineered cationic antimicrobial peptides (eCAPs) consisting exclusively of tryptophan and either lysine or arginine. Journal of Medical Microbiology. PMID 27046192 DOI: 10.1099/Jmm.0.000258  0.798
2015 Abdelbaqi S, Deslouches B, Steckbeck J, Montelaro R, Reed DS. Novel engineered cationic antimicrobial peptides display broad-spectrum activity against Francisella tularensis, Yersinia pestis, and Burkholderia pseudomallei. Journal of Medical Microbiology. PMID 26673248 DOI: 10.1099/Jmm.0.000209  0.8
2015 Craigo JK, Ezzelarab C, Cook SJ, Liu C, Horohov D, Issel CJ, Montelaro RC. Protective efficacy of centralized and polyvalent envelope immunogens in an attenuated equine lentivirus vaccine. Plos Pathogens. 11: e1004610. PMID 25569288 DOI: 10.1371/Journal.Ppat.1004610  0.366
2015 Deslouches B, Steckbeck JD, Craigo JK, Doi Y, Burns JL, Montelaro RC. Engineered cationic antimicrobial peptides to overcome multidrug resistance by ESKAPE pathogens. Antimicrobial Agents and Chemotherapy. 59: 1329-33. PMID 25421473 DOI: 10.1128/Aac.03937-14  0.787
2014 Liu C, Cook SJ, Craigo JK, Cook FR, Issel CJ, Montelaro RC, Horohov DW. Epitope shifting of gp90-specific cellular immune responses in EIAV-infected ponies. Veterinary Immunology and Immunopathology. 161: 161-9. PMID 25176006 DOI: 10.1016/J.Vetimm.2014.08.001  0.473
2014 Kuhlmann AS, Steckbeck JD, Sturgeon TJ, Craigo JK, Montelaro RC. Unique functional properties of conserved arginine residues in the lentivirus lytic peptide domains of the C-terminal tail of HIV-1 gp41. The Journal of Biological Chemistry. 289: 7630-40. PMID 24497632 DOI: 10.1074/Jbc.M113.529339  0.75
2014 Steckbeck JD, Kuhlmann AS, Montelaro RC. Structural and functional comparisons of retroviral envelope protein C-terminal domains: still much to learn. Viruses. 6: 284-300. PMID 24441863 DOI: 10.3390/V6010284  0.733
2014 Steckbeck JD, Deslouches B, Montelaro RC. Antimicrobial peptides: new drugs for bad bugs? Expert Opinion On Biological Therapy. 14: 11-4. PMID 24206062 DOI: 10.1517/14712598.2013.844227  0.791
2013 Paranjape SM, Lauer TW, Montelaro RC, Mietzner TA, Vij N. Modulation of proinflammatory activity by the engineered cationic antimicrobial peptide WLBU-2. F1000research. 2: 36. PMID 24555033 DOI: 10.12688/F1000Research.2-36.V1  0.385
2013 Craigo JK, Montelaro RC. Lessons in AIDS vaccine development learned from studies of equine infectious, anemia virus infection and immunity. Viruses. 5: 2963-76. PMID 24316675 DOI: 10.3390/V5122963  0.45
2013 Boscia AL, Akabori K, Benamram Z, Michel JA, Jablin MS, Steckbeck JD, Montelaro RC, Nagle JF, Tristram-Nagle S. Membrane structure correlates to function of LLP2 on the cytoplasmic tail of HIV-1 gp41 protein. Biophysical Journal. 105: 657-66. PMID 23931314 DOI: 10.1016/J.Bpj.2013.06.042  0.731
2013 Craigo JK, Ezzelarab C, Cook SJ, Chong L, Horohov D, Issel CJ, Montelaro RC. Envelope determinants of equine lentiviral vaccine protection. Plos One. 8: e66093. PMID 23785473 DOI: 10.1371/Journal.Pone.0066093  0.412
2013 Steckbeck JD, Sun C, Sturgeon TJ, Montelaro RC. Detailed topology mapping reveals substantial exposure of the "cytoplasmic" C-terminal tail (CTT) sequences in HIV-1 Env proteins at the cell surface. Plos One. 8: e65220. PMID 23724133 DOI: 10.1371/Journal.Pone.0065220  0.744
2013 Deslouches B, Steckbeck JD, Craigo JK, Doi Y, Mietzner TA, Montelaro RC. Rational design of engineered cationic antimicrobial peptides consisting exclusively of arginine and tryptophan, and their activity against multidrug-resistant pathogens. Antimicrobial Agents and Chemotherapy. 57: 2511-21. PMID 23507278 DOI: 10.1128/Aac.02218-12  0.803
2013 Issel CJ, Scicluna MT, Cook SJ, Cook RF, Caprioli A, Ricci I, Rosone F, Craigo JK, Montelaro RC, Autorino GL. Challenges and proposed solutions for more accurate serological diagnosis of equine infectious anaemia. The Veterinary Record. 172: 210. PMID 23161812 DOI: 10.1136/Vr-2012-100735  0.324
2013 Steckbeck JD, Kuhlmann AS, Montelaro RC. C-terminal tail of human immunodeficiency virus gp41: functionally rich and structurally enigmatic. The Journal of General Virology. 94: 1-19. PMID 23079381 DOI: 10.1099/Vir.0.046508-0  0.757
2013 Boscia AL, Akabori K, Benamram Z, Michel JA, Steckbeck JD, Jablin MS, Montelaro RC, Nagle JF, Tristram-Nagle S. LLP-2 Domain on the Cytoplasmic Terminal Tail (CTT) of HIV-1 GP41 affects T-Cell but not HIV Virion Membranes Biophysical Journal. 104: 247a. DOI: 10.1016/J.Bpj.2012.11.1389  0.731
2012 Craigo JK, Ezzelarab C, Montelaro RC. Development of a high throughput, semi-automated, infectious center cell-based ELISA for equine infectious anemia virus. Journal of Virological Methods. 185: 221-7. PMID 22820072 DOI: 10.1016/J.Jviromet.2012.07.007  0.398
2012 Liu C, Cook FR, Cook SJ, Craigo JK, Even DL, Issel CJ, Montelaro RC, Horohov DW. The determination of in vivo envelope-specific cell-mediated immune responses in equine infectious anemia virus-infected ponies. Veterinary Immunology and Immunopathology. 148: 302-10. PMID 22795699 DOI: 10.1016/J.Vetimm.2012.06.018  0.457
2012 Shen C, Ding M, Ratner D, Montelaro RC, Chen Y, Gupta P. Evaluation of cervical mucosa in transmission bottleneck during acute HIV-1 infection using a cervical tissue-based organ culture. Plos One. 7: e32539. PMID 22412886 DOI: 10.1371/Journal.Pone.0032539  0.367
2012 Bello NF, Dussupt V, Sette P, Rudd V, Nagashima K, Bibollet-Ruche F, Chen C, Montelaro RC, Hahn BH, Bouamr F. Budding of retroviruses utilizing divergent L domains requires nucleocapsid. Journal of Virology. 86: 4182-93. PMID 22345468 DOI: 10.1128/Jvi.07105-11  0.353
2012 Gearhart T, Steckbeck JD, Craigo JK, Montelaro RC. Rate and affinity binding constants determined by SPR spectroscopy reveal differential antigenicity of HIV gp120 and gp140 Retrovirology. 9: 59. DOI: 10.1186/1742-4690-9-S2-P59  0.749
2012 Kuhlmann A, Steckbeck J, Sturgeon T, Craigo J, Montelaro R. The C-terminal tail of HIV-1 envelope: a unique role for conserved LLP arginines in Env functional properties Retrovirology. 9: 325. DOI: 10.1186/1742-4690-9-S2-P325  0.736
2012 Gearhart T, Steckbeck J, Montelaro R, Craigo J. Antigenicity of soluble HIV gp140 trimers reveals differences in solution conformation for differing HIV strains Retrovirology. 9: 313. DOI: 10.1186/1742-4690-9-S2-P313  0.761
2012 Willand Z, Yu X, Cook S, Craigo J, Montelaro R, Issel C, Cook R. Equine Infectious Anemia Virus (EIAV) gag gene evolution in vivo Journal of Equine Veterinary Science. 32: S90. DOI: 10.1016/J.Jevs.2012.08.191  0.404
2012 Liu C, Cook S, Craigo J, Cook R, Issel C, Montelaro R, Horohov D. Stability differences of envelope-specific T cells responses between newly EIAV infected and inaparent carrier horses Journal of Equine Veterinary Science. 32: S86-S87. DOI: 10.1016/J.Jevs.2012.08.184  0.322
2011 McClanahan JR, Peyyala R, Mahajan R, Montelaro RC, Novak KF, Puleo DA. Bioactivity of WLBU2 peptide antibiotic in combination with bioerodible polymer. International Journal of Antimicrobial Agents. 38: 530-3. PMID 21920706 DOI: 10.1016/J.Ijantimicag.2011.07.011  0.335
2011 Steckbeck JD, Craigo JK, Barnes CO, Montelaro RC. Highly conserved structural properties of the C-terminal tail of HIV-1 gp41 protein despite substantial sequence variation among diverse clades: implications for functions in viral replication. The Journal of Biological Chemistry. 286: 27156-66. PMID 21659530 DOI: 10.1074/Jbc.M111.258855  0.722
2011 Craigo JK, Montelaro RC. EQUINE INFECTIOUS ANEMIA VIRUS INFECTION AND IMMUNITY: LESSONS FOR AIDS VACCINE DEVELOPMENT. Future Virology. 6: 139-142. PMID 21643555 DOI: 10.2217/Fvl.10.85  0.416
2011 Fernandes F, Chen K, Ehrlich LS, Jin J, Chen MH, Medina GN, Symons M, Montelaro R, Donaldson J, Tjandra N, Carter CA. Phosphoinositides direct equine infectious anemia virus gag trafficking and release. Traffic (Copenhagen, Denmark). 12: 438-51. PMID 21176037 DOI: 10.1111/J.1600-0854.2010.01153.X  0.335
2011 Costa F, Carvalho IF, Montelaro RC, Gomes P, Martins MC. Covalent immobilization of antimicrobial peptides (AMPs) onto biomaterial surfaces. Acta Biomaterialia. 7: 1431-40. PMID 21056701 DOI: 10.1016/J.Actbio.2010.11.005  0.395
2010 Steckbeck JD, Sun C, Sturgeon TJ, Montelaro RC. Topology of the C-terminal tail of HIV-1 gp41: differential exposure of the Kennedy epitope on cell and viral membranes. Plos One. 5: e15261. PMID 21151874 DOI: 10.1371/Journal.Pone.0015261  0.746
2010 Kling HM, Shipley TW, Patil SP, Kristoff J, Bryan M, Montelaro RC, Morris A, Norris KA. Relationship of Pneumocystis jiroveci humoral immunity to prevention of colonization and chronic obstructive pulmonary disease in a primate model of HIV infection. Infection and Immunity. 78: 4320-30. PMID 20660609 DOI: 10.1128/Iai.00507-10  0.374
2010 Shipley TW, Kling HM, Morris A, Patil S, Kristoff J, Guyach SE, Murphy JE, Shao X, Sciurba FC, Rogers RM, Richards T, Thompson P, Montelaro RC, Coxson HO, Hogg JC, et al. Persistent pneumocystis colonization leads to the development of chronic obstructive pulmonary disease in a nonhuman primate model of AIDS. The Journal of Infectious Diseases. 202: 302-12. PMID 20533880 DOI: 10.1086/653485  0.347
2010 Venkatachari NJ, Walker LA, Tastan O, Le T, Dempsey TM, Li Y, Yanamala N, Srinivasan A, Klein-Seetharaman J, Montelaro RC, Ayyavoo V. Human immunodeficiency virus type 1 Vpr: oligomerization is an essential feature for its incorporation into virus particles. Virology Journal. 7: 119. PMID 20529298 DOI: 10.1186/1743-422X-7-119  0.394
2010 Diedrich CR, Mattila JT, Klein E, Janssen C, Phuah J, Sturgeon TJ, Montelaro RC, Lin PL, Flynn JL. Reactivation of latent tuberculosis in cynomolgus macaques infected with SIV is associated with early peripheral T cell depletion and not virus load. Plos One. 5: e9611. PMID 20224771 DOI: 10.1371/Journal.Pone.0009611  0.346
2010 Craigo JK, Montelaro RC. EIAV envelope diversity: shaping viral persistence and encumbering vaccine efficacy. Current Hiv Research. 8: 81-6. PMID 20210783 DOI: 10.2174/157016210790416398  0.406
2010 Wang D, Harmon A, Jin J, Francis DH, Christopher-Hennings J, Nelson E, Montelaro RC, Li F. The lack of an inherent membrane targeting signal is responsible for the failure of the matrix (M1) protein of influenza A virus to bud into virus-like particles. Journal of Virology. 84: 4673-81. PMID 20181696 DOI: 10.1128/Jvi.02306-09  0.307
2010 Skinner MC, Kiselev AO, Isaacs CE, Mietzner TA, Montelaro RC, Lampe MF. Evaluation of WLBU2 peptide and 3-O-octyl-sn-glycerol lipid as active ingredients for a topical microbicide formulation targeting Chlamydia trachomatis Antimicrobial Agents and Chemotherapy. 54: 627-636. PMID 20008784 DOI: 10.1128/Aac.00635-09  0.322
2010 Steckbeck JD, Sun C, Sturgeon TJ, Montelaro RC. Distinct Topologies For the HIV-1 Transmembrane Glycoprotein gp41 C-Terminal Tail on Cellular and Viral Lipid Membranes Biophysical Journal. 98: 49a. DOI: 10.1016/J.Bpj.2009.12.282  0.74
2009 Craigo JK, Barnes S, Zhang B, Cook SJ, Howe L, Issel CJ, Montelaro RC. An EIAV field isolate reveals much higher levels of subtype variability than currently reported for the equine lentivirus family. Retrovirology. 6: 95. PMID 19843328 DOI: 10.1186/1742-4690-6-95  0.681
2009 Jin J, Sturgeon T, Weisz OA, Mothes W, Montelaro RC. HIV-1 matrix dependent membrane targeting is regulated by Gag mRNA trafficking. Plos One. 4: e6551. PMID 19662089 DOI: 10.1371/Journal.Pone.0006551  0.328
2009 Zhang B, Montelaro RC. Replication of equine infectious anemia virus in engineered mouse NIH 3T3 cells. Journal of Virology. 83: 2034-7. PMID 19073738 DOI: 10.1128/Jvi.01883-08  0.381
2009 Fidalgo-Carvalho I, Craigo JK, Barnes S, Costa-Ramos C, Montelaro RC. Characterization of an equine macrophage cell line: application to studies of EIAV infection. Veterinary Microbiology. 136: 8-19. PMID 19038510 DOI: 10.1016/J.Vetmic.2008.10.010  0.313
2009 Steckbeck JD, Sturgeon TJ, Sun C, Montelaro RC. P12-04. Topology of the C-terminal tail of HIV-1 gp41: Differential exposure of the Kennedy epitope on cell and viral membranes Retrovirology. 6. DOI: 10.1186/1742-4690-6-S3-P170  0.745
2008 Brindley MA, Zhang B, Montelaro RC, Maury W. An equine infectious anemia virus variant superinfects cells through novel receptor interactions. Journal of Virology. 82: 9425-32. PMID 18667522 DOI: 10.1128/Jvi.01142-08  0.395
2008 Sun C, Zhang B, Jin J, Montelaro RC. Binding of equine infectious anemia virus to the equine lentivirus receptor-1 is mediated by complex discontinuous sequences in the viral envelope gp90 protein. The Journal of General Virology. 89: 2011-9. PMID 18632973 DOI: 10.1099/Vir.0.83646-0  0.369
2008 Pawar SN, Mattila JT, Sturgeon TJ, Lin PL, Narayan O, Montelaro RC, Flynn JL. Comparison of the effects of pathogenic simian human immunodeficiency virus strains SHIV-89.6P and SHIV-KU2 in cynomolgus macaques. Aids Research and Human Retroviruses. 24: 643-54. PMID 18366326 DOI: 10.1089/Aid.2007.0238  0.369
2008 Tagmyer TL, Craigo JK, Cook SJ, Even DL, Issel CJ, Montelaro RC. Envelope determinants of equine infectious anemia virus vaccine protection and the effects of sequence variation on immune recognition. Journal of Virology. 82: 4052-63. PMID 18234792 DOI: 10.1128/Jvi.02028-07  0.443
2008 Zhang B, Sun C, Jin S, Cascio M, Montelaro RC. Mapping of equine lentivirus receptor 1 residues critical for equine infectious anemia virus envelope binding. Journal of Virology. 82: 1204-13. PMID 18032504 DOI: 10.1128/Jvi.01393-07  0.345
2008 Gonzalez IA, Wong X, DeAlmeida D, Yurko RB, Watkins SC, Islam K, Montelaro RC, El-Ghannam A, Mietzner TA. Peptides as potent antimicrobials tethered to a solid surface: Implications for medical devices Nature Precedings. DOI: 10.1038/Npre.2008.1967.1  0.309
2007 Craigo JK, Zhang B, Barnes S, Tagmyer TL, Cook SJ, Issel CJ, Montelaro RC. Envelope variation as a primary determinant of lentiviral vaccine efficacy. Proceedings of the National Academy of Sciences of the United States of America. 104: 15105-10. PMID 17846425 DOI: 10.1073/Pnas.0706449104  0.365
2007 Jin J, Sturgeon T, Chen C, Watkins SC, Weisz OA, Montelaro RC. Distinct intracellular trafficking of equine infectious anemia virus and human immunodeficiency virus type 1 Gag during viral assembly and budding revealed by bimolecular fluorescence complementation assays. Journal of Virology. 81: 11226-35. PMID 17686839 DOI: 10.1128/Jvi.00431-07  0.363
2007 Deslouches B, Gonzalez IA, DeAlmeida D, Islam K, Steele C, Montelaro RC, Mietzner TA. De novo-derived cationic antimicrobial peptide activity in a murine model of Pseudomonas aeruginosa bacteraemia. The Journal of Antimicrobial Chemotherapy. 60: 669-72. PMID 17623696 DOI: 10.1093/Jac/Dkm253  0.736
2007 Tagmyer TL, Craigo JK, Cook SJ, Issel CJ, Montelaro RC. Envelope-specific T-helper and cytotoxic T-lymphocyte responses associated with protective immunity to equine infectious anemia virus. The Journal of General Virology. 88: 1324-36. PMID 17374779 DOI: 10.1099/Vir.0.82391-0  0.459
2007 Toapanta FR, Craigo JK, Montelaro RC, Ross TM. Reduction of anti-HIV-1 Gag immune responses during co-immunization: immune interference by the HIV-1 envelope. Current Hiv Research. 5: 199-209. PMID 17346134 DOI: 10.2174/157016207780077057  0.397
2007 Novak KF, Diamond WJ, Kirakodu S, Peyyala R, Anderson KW, Montelaro RC, Mietzner TA. Efficacy of the de novo-derived antimicrobial peptide WLBU2 against oral bacteria. Antimicrobial Agents and Chemotherapy. 51: 1837-9. PMID 17325219 DOI: 10.1128/Aac.00924-06  0.34
2007 Craigo JK, Durkin S, Sturgeon TJ, Tagmyer T, Cook SJ, Issel CJ, Montelaro RC. Immune suppression of challenged vaccinates as a rigorous assessment of sterile protection by lentiviral vaccines. Vaccine. 25: 834-45. PMID 17023099 DOI: 10.1016/J.Vaccine.2006.09.040  0.409
2006 Steckbeck JD, Grieser HJ, Sturgeon T, Taber R, Chow A, Bruno J, Murphy-Corb M, Montelaro RC, Cole KS. Dynamic evolution of antibody populations in a rhesus macaque infected with attenuated simian immunodeficiency virus identified by surface plasmon resonance. Journal of Medical Primatology. 35: 248-60. PMID 16872288 DOI: 10.1111/J.1600-0684.2006.00173.X  0.742
2006 Craigo JK, Sturgeon TJ, Cook SJ, Issel CJ, Leroux C, Montelaro RC. Apparent elimination of EIAV ancestral species in a long-term inapparent carrier. Virology. 344: 340-53. PMID 16226288 DOI: 10.1016/J.Virol.2005.09.006  0.341
2005 Jin S, Zhang B, Weisz OA, Montelaro RC. Receptor-mediated entry by equine infectious anemia virus utilizes a pH-dependent endocytic pathway. Journal of Virology. 79: 14489-97. PMID 16282448 DOI: 10.1128/Jvi.79.23.14489-14497.2005  0.349
2005 Chen C, Vincent O, Jin J, Weisz OA, Montelaro RC. Functions of early (AP-2) and late (AIP1/ALIX) endocytic proteins in equine infectious anemia virus budding. The Journal of Biological Chemistry. 280: 40474-80. PMID 16215227 DOI: 10.1074/Jbc.M509317200  0.352
2005 Steckbeck JD, Orlov I, Chow A, Grieser H, Miller K, Bruno J, Robinson JE, Montelaro RC, Cole KS. Kinetic rates of antibody binding correlate with neutralization sensitivity of variant simian immunodeficiency virus strains. Journal of Virology. 79: 12311-20. PMID 16160158 DOI: 10.1128/Jvi.79.19.12311-12320.2005  0.758
2005 Deslouches B, Islam K, Craigo JK, Paranjape SM, Montelaro RC, Mietzner TA. Activity of the de novo engineered antimicrobial peptide WLBU2 against Pseudomonas aeruginosa in human serum and whole blood: implications for systemic applications. Antimicrobial Agents and Chemotherapy. 49: 3208-16. PMID 16048927 DOI: 10.1128/Aac.49.8.3208-3216.2005  0.742
2005 Jin S, Chen C, Montelaro RC. Equine infectious anemia virus Gag p9 function in early steps of virus infection and provirus production. Journal of Virology. 79: 8793-801. PMID 15994773 DOI: 10.1128/Jvi.79.14.8793-8801.2005  0.38
2005 Zhang B, Jin S, Jin J, Li F, Montelaro RC. A tumor necrosis factor receptor family protein serves as a cellular receptor for the macrophage-tropic equine lentivirus. Proceedings of the National Academy of Sciences of the United States of America. 102: 9918-23. PMID 15985554 DOI: 10.1073/Pnas.0501560102  0.369
2005 Cook RF, Cook SJ, Bolin PS, Howe LJ, Zhou W, Montelaro RC, Issel CJ. Genetic immunization with codon-optimized equine infectious anemia virus (EIAV) surface unit (SU) envelope protein gene sequences stimulates immune responses in ponies. Veterinary Microbiology. 108: 23-37. PMID 15885929 DOI: 10.1016/J.Vetmic.2005.04.004  0.657
2005 Phadke SM, Deslouches B, Hileman SE, Montelaro RC, Wiesenfeld HC, Mietzner TA. Antimicrobial peptides in mucosal secretions: the importance of local secretions in mitigating infection. The Journal of Nutrition. 135: 1289-93. PMID 15867326 DOI: 10.1093/Jn/135.5.1289  0.753
2005 Abdel-Motal UM, Gillis J, Manson K, Wyand M, Montefiori D, Stefano-Cole K, Montelaro RC, Altman JD, Johnson RP. Kinetics of expansion of SIV Gag-specific CD8+ T lymphocytes following challenge of vaccinated macaques. Virology. 333: 226-38. PMID 15721357 DOI: 10.1016/J.Virol.2004.12.030  0.336
2005 Craigo JK, Li F, Steckbeck JD, Durkin S, Howe L, Cook SJ, Issel C, Montelaro RC. Discerning an effective balance between equine infectious anemia virus attenuation and vaccine efficacy. Journal of Virology. 79: 2666-77. PMID 15708986 DOI: 10.1128/Jvi.79.5.2666-2677.2005  0.8
2005 Kalia V, Sarkar S, Gupta P, Montelaro RC. Antibody neutralization escape mediated by point mutations in the intracytoplasmic tail of human immunodeficiency virus type 1 gp41. Journal of Virology. 79: 2097-107. PMID 15681412 DOI: 10.1128/Jvi.79.4.2097-2107.2005  0.716
2005 Deslouches B, Phadke SM, Lazarevic V, Cascio M, Islam K, Montelaro RC, Mietzner TA. De novo generation of cationic antimicrobial peptides: influence of length and tryptophan substitution on antimicrobial activity. Antimicrobial Agents and Chemotherapy. 49: 316-22. PMID 15616311 DOI: 10.1128/Aac.49.1.316-322.2005  0.745
2005 Howe L, Craigo JK, Issel CJ, Montelaro RC. Specificity of serum neutralizing antibodies induced by transient immune suppression of inapparent carrier ponies infected with a neutralization-resistant equine infectious anemia virus envelope strain. The Journal of General Virology. 86: 139-49. PMID 15604441 DOI: 10.1099/Vir.0.80374-0  0.697
2005 Leroux C, Montelaro RC, Sublimec E, Cadoré JL. EIAV (equine infectious anemia virus): To better understand the lentiviral pathogenesis Virologie. 9: 289-300.  0.328
2004 Craigo JK, Patterson BK, Paranjpe S, Kulka K, Ding M, Mellors J, Montelaro RC, Gupta P. Persistent HIV type 1 infection in semen and blood compartments in patients after long-term potent antiretroviral therapy. Aids Research and Human Retroviruses. 20: 1196-209. PMID 15588342 DOI: 10.1089/Aid.2004.20.1196  0.346
2004 Jin S, Issel CJ, Montelaro RC. Serological method using recombinant S2 protein to differentiate equine infectious anemia virus (EIAV)-infected and EIAV-vaccinated horses. Clinical and Diagnostic Laboratory Immunology. 11: 1120-9. PMID 15539516 DOI: 10.1128/Cdli.11.6.1120-1129.2004  0.424
2004 Leroux C, Cadoré JL, Montelaro RC. Equine Infectious Anemia Virus (EIAV): what has HIV's country cousin got to tell us? Veterinary Research. 35: 485-512. PMID 15236678 DOI: 10.1051/Vetres:2004020  0.442
2004 Cole KS, Steckbeck JD, Rowles JL, Desrosiers RC, Montelaro RC. Removal of N-linked glycosylation sites in the V1 region of simian immunodeficiency virus gp120 results in redirection of B-cell responses to V3. Journal of Virology. 78: 1525-39. PMID 14722307 DOI: 10.1128/Jvi.78.3.1525-1539.2004  0.796
2004 Chen C, Weisz OA, Stolz DB, Watkins SC, Montelaro RC. Differential effects of actin cytoskeleton dynamics on equine infectious anemia virus particle production. Journal of Virology. 78: 882-91. PMID 14694119 DOI: 10.1128/Jvi.78.2.882-891.2004  0.34
2004 Shehu-Xhilaga M, Ablan S, Demirov DG, Chen C, Montelaro RC, Freed EO. Late domain-dependent inhibition of equine infectious anemia virus budding. Journal of Virology. 78: 724-32. PMID 14694104 DOI: 10.1128/Jvi.78.2.724-732.2004  0.324
2003 Phadke SM, Islam K, Deslouches B, Kapoor SA, Beer Stolz D, Watkins SC, Montelaro RC, Pilewski JM, Mietzner TA. Selective toxicity of engineered lentivirus lytic peptides in a CF airway cell model. Peptides. 24: 1099-107. PMID 14612179 DOI: 10.1016/J.Peptides.2003.07.001  0.724
2003 Sarkar S, Kalia V, Murphey-Corb M, Montelaro RC, Reinhart TA. Expression of IFN-gamma induced CXCR3 agonist chemokines and compartmentalization of CXCR3+ cells in the periphery and lymph nodes of rhesus macaques during simian immunodeficiency virus infection and acquired immunodeficiency syndrome. Journal of Medical Primatology. 32: 247-64. PMID 14498985 DOI: 10.1034/J.1600-0684.2003.00031.X  0.691
2003 Chen C, Montelaro RC. Characterization of RNA elements that regulate gag-pol ribosomal frameshifting in equine infectious anemia virus. Journal of Virology. 77: 10280-7. PMID 12970412 DOI: 10.1128/Jvi.77.19.10280-10287.2003  0.334
2003 Sarkar S, Kalia V, Montelaro RC. Caspase-mediated apoptosis and cell death of rhesus macaque CD4+ T-cells due to cryopreservation of peripheral blood mononuclear cells can be rescued by cytokine treatment after thawing. Cryobiology. 47: 44-58. PMID 12963412 DOI: 10.1016/S0011-2240(03)00068-3  0.641
2003 Cook RF, Cook SJ, Berger SL, Leroux C, Ghabrial NN, Gantz M, Bolin PS, Mousel MR, Montelaro RC, Issel CJ. Enhancement of equine infectious anemia virus virulence by identification and removal of suboptimal nucleotides. Virology. 313: 588-603. PMID 12954224 DOI: 10.1016/S0042-6822(03)00351-9  0.352
2003 Reis JK, Craigo JK, Cook SJ, Issel CJ, Montelaro RC. Characterization of EIAV LTR variability and compartmentalization in various reservoir tissues of long-term inapparent carrier ponies. Virology. 311: 169-80. PMID 12832214 DOI: 10.1016/S0042-6822(03)00168-5  0.396
2003 Li F, Craigo JK, Howe L, Steckbeck JD, Cook S, Issel C, Montelaro RC. A live attenuated equine infectious anemia virus proviral vaccine with a modified S2 gene provides protection from detectable infection by intravenous virulent virus challenge of experimentally inoculated horses. Journal of Virology. 77: 7244-53. PMID 12805423 DOI: 10.1128/Jvi.77.13.7244-7253.2003  0.806
2003 Kalia V, Sarkar S, Gupta P, Montelaro RC. Rational site-directed mutations of the LLP-1 and LLP-2 lentivirus lytic peptide domains in the intracytoplasmic tail of human immunodeficiency virus type 1 gp41 indicate common functions in cell-cell fusion but distinct roles in virion envelope incorporation. Journal of Virology. 77: 3634-46. PMID 12610139 DOI: 10.1128/Jvi.77.6.3634-3646.2003  0.699
2003 Van Rompay KK, Greenier JL, Cole KS, Earl P, Moss B, Steckbeck JD, Pahar B, Rourke T, Montelaro RC, Canfield DR, Tarara RP, Miller C, McChesney MB, Marthas ML. Immunization of newborn rhesus macaques with simian immunodeficiency virus (SIV) vaccines prolongs survival after oral challenge with virulent SIVmac251. Journal of Virology. 77: 179-90. PMID 12477823 DOI: 10.1128/Jvi.77.1.179-190.2003  0.754
2002 Paranjpe S, Craigo J, Patterson B, Ding M, Barroso P, Harrison L, Montelaro R, Gupta P. Subcompartmentalization of HIV-1 quasispecies between seminal cells and seminal plasma indicates their origin in distinct genital tissues. Aids Research and Human Retroviruses. 18: 1271-80. PMID 12487815 DOI: 10.1089/088922202320886316  0.306
2002 Sarkar S, Kalia V, Murphey-Corb M, Montelaro RC. Characterization of CD4+ T helper cell fine specificity to the envelope glycoproteins of simian immunodeficiency virus. Journal of Medical Primatology. 31: 194-204. PMID 12390542 DOI: 10.1034/J.1600-0684.2002.02006.X  0.735
2002 Howe L, Leroux C, Issel CJ, Montelaro RC. Equine infectious anemia virus envelope evolution in vivo during persistent infection progressively increases resistance to in vitro serum antibody neutralization as a dominant phenotype. Journal of Virology. 76: 10588-97. PMID 12368301 DOI: 10.1128/Jvi.76.21.10588-10597.2002  0.698
2002 Zhou W, Cook RF, Cook SJ, Hammond SA, Rushlow K, Ghabrial NN, Berger SL, Montelaro RC, Issel CJ. Multiple RNA splicing and the presence of cryptic RNA splice donor and acceptor sites may contribute to low expression levels and poor immunogenicity of potential DNA vaccines containing the env gene of equine infectious anemia virus (EIAV). Veterinary Microbiology. 88: 127-51. PMID 12135633 DOI: 10.1016/S0378-1135(02)00099-8  0.36
2002 O'Sullivan CE, Peng R, Cole KS, Montelaro RC, Sturgeon T, Jenson HB, Ling PD. Epstein-Barr virus and human immunodeficiency virus serological responses and viral burdens in HIV-infected patients treated with HAART. Journal of Medical Virology. 67: 320-6. PMID 12116021 DOI: 10.1002/Jmv.10080  0.389
2002 Craigo JK, Leroux C, Howe L, Steckbeck JD, Cook SJ, Issel CJ, Montelaro RC. Transient immune suppression of inapparent carriers infected with a principal neutralizing domain-deficient equine infectious anaemia virus induces neutralizing antibodies and lowers steady-state virus replication. The Journal of General Virology. 83: 1353-9. PMID 12029150 DOI: 10.1099/0022-1317-83-6-1353  0.817
2002 Phadke SM, Lazarevic V, Bahr CC, Islam K, Stolz DB, Watkins S, Tencza SB, Vogel HJ, Montelaro RC, Mietzner TA. Lentivirus lytic peptide 1 perturbs both outer and inner membranes of Serratia marcescens. Antimicrobial Agents and Chemotherapy. 46: 2041-5. PMID 12019137 DOI: 10.1128/Aac.46.6.2041-2045.2002  0.331
2002 Sarkar S, Kalia V, Murphey-Corb M, Montelaro RC. Detailed analysis of CD4+ Th responses to envelope and Gag proteins of simian immunodeficiency virus reveals an exclusion of broadly reactive Th epitopes from the glycosylated regions of envelope. Journal of Immunology (Baltimore, Md. : 1950). 168: 4001-11. PMID 11937557 DOI: 10.4049/Jimmunol.168.8.4001  0.729
2002 Patnaik A, Chau V, Li F, Montelaro RC, Wills JW. Budding of equine infectious anemia virus is insensitive to proteasome inhibitors. Journal of Virology. 76: 2641-7. PMID 11861830 DOI: 10.1128/Jvi.76.6.2641-2647.2002  0.398
2002 Li F, Chen C, Puffer BA, Montelaro RC. Functional replacement and positional dependence of homologous and heterologous L domains in equine infectious anemia virus replication. Journal of Virology. 76: 1569-77. PMID 11799151 DOI: 10.1128/Jvi.76.4.1569-1577.2002  0.357
2001 Cole KS, Alvarez M, Elliott DH, Lam H, Martin E, Chau T, Micken K, Rowles JL, Clements JE, Murphey-Corb M, Montelaro RC, Robinson JE. Characterization of neutralization epitopes of simian immunodeficiency virus (SIV) recognized by rhesus monoclonal antibodies derived from monkeys infected with an attenuated SIV strain. Virology. 290: 59-73. PMID 11883006 DOI: 10.1006/Viro.2001.1144  0.819
2001 Schibli DJ, Montelaro RC, Vogel HJ. The membrane-proximal tryptophan-rich region of the HIV glycoprotein, gp41, forms a well-defined helix in dodecylphosphocholine micelles. Biochemistry. 40: 9570-8. PMID 11583156 DOI: 10.1021/Bi010640U  0.383
2001 Chen C, Li F, Montelaro RC. Functional roles of equine infectious anemia virus Gag p9 in viral budding and infection Journal of Virology. 75: 9762-9770. PMID 11559809 DOI: 10.1128/Jvi.75.20.9762-9770.2001  0.381
2001 Chen M, Shi C, Kalia V, Tencza SB, Montelaro RC, Gupta P. HIV gp120 V(1)/V(2) and C(2)-V(3) domains glycoprotein compatibility is required for viral replication. Virus Research. 79: 91-101. PMID 11551649 DOI: 10.1016/S0168-1702(01)00322-7  0.596
2001 Leroux C, Craigo JK, Issel CJ, Montelaro RC. Equine infectious anemia virus genomic evolution in progressor and nonprogressor ponies Journal of Virology. 75: 4570-4583. PMID 11312327 DOI: 10.1128/Jvi.75.10.4570-4583.2001  0.397
2001 Cook SJ, Cook RF, Montelaro RC, Issel CJ. Differential responses of Equus caballus and Equus asinus to infection with two pathogenic strains of equine infectious anemia virus. Veterinary Microbiology. 79: 93-109. PMID 11230932 DOI: 10.1016/S0378-1135(00)00348-5  0.397
2001 Yuan T, Tencza S, Mietzner TA, Montelaro RC, Vogel HJ. Calmodulin binding properties of peptide analogues and fragments of the calmodulin-binding domain of simian immunodeficiency virus transmembrane glycoprotein 41 Biopolymers. 58: 50-62. PMID 11072229 DOI: 10.1002/1097-0282(200101)58:1<50::Aid-Bip60>3.0.Co;2-S  0.377
2000 Cole KS, Paliotti MJ, Murphey-Corb M, Montelaro RC. Maturation of envelope-specific antibody responses to linear determinants in monkeys inoculated with attenuated SIV. Journal of Medical Primatology. 29: 220-30. PMID 11085584 DOI: 10.1034/J.1600-0684.2000.290315.X  0.447
2000 Lockridge KM, Chien M, Dean GA, Stefano Cole K, Montelaro RC, Luciw PA, Sparger EE. Protective immunity against feline immunodeficiency virus induced by inoculation with vif-deleted proviral DNA Virology. 273: 67-79. PMID 10891409 DOI: 10.1006/Viro.2000.0395  0.418
2000 Gupta P, Leroux C, Patterson BK, Kingsley L, Rinaldo C, Ding M, Chen Y, Kulka K, Buchanan W, McKeon B, Montelaro R. Human immunodeficiency virus type 1 shedding pattern in semen correlates with the compartmentalization of viral Quasi species between blood and semen. The Journal of Infectious Diseases. 182: 79-87. PMID 10882584 DOI: 10.1086/315644  0.34
2000 Hammond SA, Li F, McKeon BM, Cook SJ, Issel CJ, Montelaro RC. Immune responses and viral replication in long-term inapparent carrier ponies inoculated with equine infectious anemia virus. Journal of Virology. 74: 5968-81. PMID 10846078 DOI: 10.1128/Jvi.74.13.5968-5981.2000  0.411
2000 Tencza SB, Islam KR, Kalia V, Nasir MS, Jolley ME, Montelaro RC. Development of a fluorescence polarization-based diagnostic assay for equine infectious anemia virus. Journal of Clinical Microbiology. 38: 1854-9. PMID 10790112 DOI: 10.1128/Jcm.38.5.1854-1859.2000  0.625
2000 Harrold SM, Cook SJ, Cook RF, Rushlow KE, Issel CJ, Montelaro RC. Tissue sites of persistent infection and active replication of equine infectious anemia virus during acute disease and asymptomatic infection in experimentally infected equids. Journal of Virology. 74: 3112-21. PMID 10708426 DOI: 10.1128/Jvi.74.7.3112-3121.2000  0.401
2000 Li F, Leroux C, Craigo JK, Cook SJ, Issel CJ, Montelaro RC. The S2 gene of equine infectious anemia virus is a highly conserved determinant of viral replication and virulence properties in experimentally infected ponies. Journal of Virology. 74: 573-9. PMID 10590152 DOI: 10.1128/Jvi.74.1.573-579.2000  0.361
1999 Plymale DR, Comardelle AM, Fermi CD, Martin DS, Costin JM, Norris CH, Tencza SB, Mietzner TA, Montelaro RC, Garry RF. Concentration-dependent differential induction of necrosis or apoptosis by HIV-1 lytic peptide 1. Peptides. 20: 1275-83. PMID 10612441 DOI: 10.1016/S0196-9781(99)00132-1  0.396
1999 Hammond SA, Raabe ML, Issel CJ, Montelaro RC. Evaluation of antibody parameters as potential correlates of protection or enhancement by experimental vaccines to equine infectious anemia virus. Virology. 262: 416-30. PMID 10502520 DOI: 10.1006/Viro.1999.9939  0.406
1999 Tencza SB, Creighton DJ, Yuan T, Vogel HJ, Montelaro RC, Mietzner TA. Lentivirus-derived antimicrobial peptides: Increased potency by sequence engineering and dimerization Journal of Antimicrobial Chemotherapy. 44: 33-41. PMID 10459808 DOI: 10.1093/Jac/44.1.33  0.395
1999 Raabe ML, Issel CJ, Montelaro RC. In vitro antibody-dependent enhancement assays are insensitive indicators of in vivo vaccine enhancement of equine infectious anemia virus Virology. 259: 416-427. PMID 10388665 DOI: 10.1006/Viro.1999.9772  0.427
1999 Johnson RP, Lifson JD, Czajak SC, Cole KS, Manson KH, Glickman R, Yang J, Montefiori DC, Montelaro R, Wyand MS, Desrosiers RC. Highly attenuated vaccine strains of simian immunodeficiency virus protect against vaginal challenge: inverse relationship of degree of protection with level of attenuation. Journal of Virology. 73: 4952-61. PMID 10233957 DOI: 10.1128/Jvi.73.6.4952-4961.1999  0.382
1999 Hammond SA, Cook SJ, Falo LD, Issel CJ, Montelaro RC. A particulate viral protein vaccine reduces viral load and delays progression to disease in immunized ponies challenged with equine infectious anemia virus. Virology. 254: 37-49. PMID 9927572 DOI: 10.1006/Viro.1998.9550  0.438
1998 Puffer BA, Watkins SC, Montelaro RC. Equine infectious anemia virus gag polyprotein late domain specifically recruits cellular AP-2 adapter protein complexes during virion assembly Journal of Virology. 72: 10218-10221. PMID 9811764 DOI: 10.1128/Jvi.72.12.10218-10221.1998  0.351
1998 Robinson JE, Cole KS, Elliott DH, Lam H, Amedee AM, Means R, Desrosiers RC, Clements J, Montelaro RC, Murphey-Corb M. Production and characterization of SIV envelope-specific rhesus monoclonal antibodies from a macaque asymptomatically infected with a live SIV vaccine. Aids Research and Human Retroviruses. 14: 1253-62. PMID 9764909 DOI: 10.1089/Aid.1998.14.1253  0.361
1998 Tung FYT, Rinaldo C.R. J, Montelaro RC. Replication-defective HIV as a vaccine candidate Aids Research and Human Retroviruses. 14: 1247-1252. PMID 9764908 DOI: 10.1089/Aid.1998.14.1247  0.424
1998 Li F, Puffer BA, Montelaro RC. The S2 gene of equine infectious anemia virus is dispensable for viral replication in vitro Journal of Virology. 72: 8344-8348. PMID 9733881 DOI: 10.1128/Jvi.72.10.8344-8348.1998  0.355
1998 Cole KS, Murphey-Corb M, Narayan O, Joag SV, Shaw GM, Montelaro RC. Common themes of antibody maturation to simian immunodeficiency virus, simian-human immunodeficiency virus, and human immunodeficiency virus type 1 infections. Journal of Virology. 72: 7852-9. PMID 9733822 DOI: 10.1128/Jvi.72.10.7852-7859.1998  0.486
1998 Hammond SA, Issel CJ, Montelaro RC. General method for the detection and in vitro expansion of equine cytolytic T lymphocytes. Journal of Immunological Methods. 213: 73-85. PMID 9671126 DOI: 10.1016/S0022-1759(98)00024-6  0.337
1998 Raabe MR, Issel CJ, Montelaro RC. Equine monocyte-derived macrophage cultures and their applications for infectivity and neutralization studies of equine infectious anemia virus Journal of Virological Methods. 71: 87-104. PMID 9628225 DOI: 10.1016/S0166-0934(97)00204-8  0.325
1998 Raabe ML, Issel CJ, Cook SJ, Cook RF, Woodson B, Montelaro RC. Immunization with a recombinant envelope protein (rgp90) of EIAV produces a spectrum of vaccine efficacy ranging from lack of clinical disease to severe enhancement. Virology. 245: 151-62. PMID 9614876 DOI: 10.1006/Viro.1998.9142  0.363
1998 Van Rompay KK, Berardi CJ, Dillard-Telm S, Tarara RP, Canfield DR, Valverde CR, Montefiori DC, Cole KS, Montelaro RC, Miller CJ, Marthas ML. Passive immunization of newborn rhesus macaques prevents oral simian immunodeficiency virus infection. The Journal of Infectious Diseases. 177: 1247-59. PMID 9593009 DOI: 10.1086/515270  0.423
1998 Beary TP, Tencza SB, Mietzner TA, Montelaro RC. Interruption of T-cell signal transduction by lentivirus lytic peptides from HIV-1 transmembrane protein Journal of Peptide Research. 51: 75-79. PMID 9495594 DOI: 10.1111/J.1399-3011.1998.Tb00419.X  0.359
1998 Cook RF, Leroux C, Cook SJ, Berger SL, Lichtenstein DL, Ghabrial NN, Montelaro RC, Issel CJ. Development and characterization of an in vivo pathogenic molecular clone of equine infectious anemia virus. Journal of Virology. 72: 1383-93. PMID 9445039 DOI: 10.1128/Jvi.72.2.1383-1393.1998  0.38
1997 Comardelle AM, Norris CH, Plymale DR, Gatti PJ, Choi B, Fermin CD, Haislip AM, Tencza SB, Mietzner TA, Montelaro RC, Garry RF. A synthetic peptide corresponding to the carboxy terminus of human immunodeficiency virus type 1 transmembrane glycoprotein induces alterations in the ionic permeability of Xenopus laevis oocytes. Aids Research and Human Retroviruses. 13: 1525-32. PMID 9390752 DOI: 10.1089/Aid.1997.13.1525  0.392
1997 Leroux C, Issel CJ, Montelaro RC. Novel and dynamic evolution of equine infectious anemia virus genomic quasispecies associated with sequential disease cycles in an experimentally infected pony Journal of Virology. 71: 9627-9639. PMID 9371627 DOI: 10.1128/Jvi.71.12.9627-9639.1997  0.395
1997 Tencza SB, Douglass JP, Creighton DJ, Montelaro RC, Mietzner TA. Novel antimicrobial peptides derived from human immunodeficiency virus type 1 and other lentivirus transmembrane proteins Antimicrobial Agents and Chemotherapy. 41: 2394-2398. PMID 9371339 DOI: 10.1128/Aac.41.11.2394  0.419
1997 Fuller DH, Simpson L, Cole KS, Clements JE, Panicali DL, Montelaro RC, Murphey-Corb M, Haynes JR. Gene gun-based nucleic acid immunization alone or in combination with recombinant vaccinia vectors suppresses virus burden in rhesus macaques challenged with a heterologous SIV. Immunology and Cell Biology. 75: 389-96. PMID 9315483 DOI: 10.1038/Icb.1997.61  0.343
1997 Cole KS, Rowles JL, Murphey-Corb M, Clements JE, Robinson J, Montelaro RC. A model for the maturation of protective antibody responses to SIV envelope proteins in experimentally immunized monkeys. Journal of Medical Primatology. 26: 51-8. PMID 9271189 DOI: 10.1111/J.1600-0684.1997.Tb00319.X  0.813
1997 Puffer BA, Parent LJ, Wills JW, Montelaro RC. Equine infectious anemia virus utilizes a YXXL motif within the late assembly domain of the Gag p9 protein Journal of Virology. 71: 6541-6546. PMID 9261374 DOI: 10.1128/Jvi.71.9.6541-6546.1997  0.354
1997 Cole KS, Rowles JL, Jagerski BA, Murphey-Corb M, Unangst T, Clements JE, Robinson J, Wyand MS, Desrosiers RC, Montelaro RC. Evolution of envelope-specific antibody responses in monkeys experimentally infected or immunized with simian immunodeficiency virus and its association with the development of protective immunity. Journal of Virology. 71: 5069-79. PMID 9188572 DOI: 10.1128/Jvi.71.7.5069-5079.1997  0.813
1997 Tencza SB, Mietzner TA, Montelaro RC. Calmodulin-binding function of LLP segments from the HIV type 1 transmembrane protein is conserved among natural sequence variants Aids Research and Human Retroviruses. 13: 263-269. PMID 9115814 DOI: 10.1089/Aid.1997.13.263  0.379
1997 Hammond SA, Cook SJ, Lichtenstein DL, Issel CJ, Montelaro RC. Maturation of the cellular and humoral immune responses to persistent infection in horses by equine infectious anemia virus is a complex and lengthy process. Journal of Virology. 71: 3840-52. PMID 9094660 DOI: 10.1128/Jvi.71.5.3840-3852.1997  0.442
1997 Cole KS, Rowles JL, Jagerski BA, Murphey-Corb M, Unangst T, Clements JE, Robinson J, Wyand MS, Desrosiers RC, Montelaro RC. Evolution of envelope-specific antibody responses in monkeys experimentally infected or immunized with simian immunodeficiency virus and its association with the development of protective immunity. Journal of Virology. 71: 5069-5079. DOI: 10.1128/jvi.71.7.5069-5079.1997  0.81
1996 Montelaro RC, Grund C, Raabe M, Woodson B, Cook RF, Cook S, Issel CJ. Characterization of protective and enhancing immune responses to equine infectious anemia virus resulting from experimental vaccines. Aids Research and Human Retroviruses. 12: 413-5. PMID 8882322 DOI: 10.1089/Aid.1996.12.413  0.389
1996 Langemeier JL, Cook SJ, Cook RF, Rushlow KE, Montelaro RC, Issel CJ. Detection of equine infectious anemia viral RNA in plasma samples from recently infected and long-term inapparent carrier animals by PCR. Journal of Clinical Microbiology. 34: 1481-7. PMID 8735102 DOI: 10.1128/Jcm.34.6.1481-1487.1996  0.369
1996 Lichtenstein DL, Issel CJ, Montelaro RC. Genomic quasispecies associated with the initiation of infection and disease in ponies experimentally infected with equine infectious anemia virus Journal of Virology. 70: 3346-3354. PMID 8648664 DOI: 10.1128/Jvi.70.6.3346-3354.1996  0.402
1996 Grund CH, Lechman ER, Pezzuolo NA, Issel CJ, Montelaro RC. Fine specificity of equine infectious anaemia virus gp90-specific antibodies associated with protective and enhancing immune responses in experimentally infected and immunized ponies Journal of General Virology. 77: 435-442. PMID 8601778 DOI: 10.1099/0022-1317-77-3-435  0.488
1995 Cook RF, Berger SL, Rushlow KE, McManus JM, Cook SJ, Harrold S, Raabe ML, Montelaro RC, Issel CJ. Enhanced sensitivity to neutralizing antibodies in a variant of equine infectious anemia virus is linked to amino acid substitutions in the surface unit envelope glycoprotein. Journal of Virology. 69: 1493-9. PMID 7853482 DOI: 10.1128/Jvi.69.3.1493-1499.1995  0.386
1995 Ohkawa S, Xu K, Wilson LA, Montelaro R, Martin LN, Murphey-Corb M. Analysis of envelope glycoprotein-specific antibodies from SIV-infected and gp110-immunized monkeys in ACC and ADCC assays Aids Research and Human Retroviruses. 11: 395-403. PMID 7786584 DOI: 10.1089/Aid.1995.11.395  0.447
1995 Gallaher WR, Ball JM, Garry RF, Martin-Amedee AM, Montelaro RC. A general model for the surface glycoproteins of HIV and other retroviruses Aids Research and Human Retroviruses. 11: 191-202. PMID 7742034 DOI: 10.1089/Aid.1995.11.191  0.404
1995 Clements JE, Montelaro RC, Zink MC, Amedee AM, Miller S, Trichel AM, Jagerski B, Hauer D, Martin LN, Bohm RP, Murphey-Corb M. Cross-protective immune responses induced in rhesus macaques by immunization with attenuated macrophage-tropic simian immunodeficiency virus Journal of Virology. 69: 2737-2744. PMID 7707496 DOI: 10.1128/Jvi.69.5.2737-2744.1995  0.472
1995 Parent LJ, Bennett RP, Craven RC, Nelle TD, Krishna NK, Bowzard JB, Wilson CB, Puffer BA, Montelaro RC, Wills JW. Positionally independent and exchangeable late budding functions of the rous sarcoma virus and human immunodeficiency virus Gag proteins Journal of Virology. 69: 5455-5460. PMID 7636991 DOI: 10.1128/Jvi.69.9.5455-5460.1995  0.383
1995 Tencza SB, Miller MA, Islam K, Mietzner TA, Montelaro RC. Effect of amino acid substitutions on calmodulin binding and cytolytic properties of the LLP-1 peptide segment of human immunodeficiency virus type 1 transmembrane protein Journal of Virology. 69: 5199-5202. PMID 7609094 DOI: 10.1128/Jvi.69.8.5199-5202.1995  0.444
1995 Lichtenstein DL, Rushlow KE, Cook RF, Raabe ML, Swardson CJ, Kociba GJ, Issel CJ, Montelaro RC. Replication in vitro and in vivo of an equine infectious anemia virus mutant deficient in dUTPase activity. Journal of Virology. 69: 2881-2888. DOI: 10.1128/Jvi.69.5.2881-2888.1995  0.405
1994 Fontenot JD, Tjandra N, Ho C, Andrews PC, Montelaro RC. Fstructure and self assembly of a retrovirus (Felv) proline rich neutralization domain Journal of Biomolecular Structure and Dynamics. 11: 821-836. PMID 8204217 DOI: 10.1080/07391102.1994.10508035  0.335
1994 Wang SZ, Rushlow KE, Issel CJ, Cook RF, Cook SJ, Raabe ML, Chong YH, Costa L, Montelaro RC. Enhancement of EIAV replication and disease by immunization with a baculovirus-expressed recombinant envelope surface glycoprotein. Virology. 199: 247-51. PMID 8116252 DOI: 10.1006/Viro.1994.1120  0.43
1994 Payne SL, Rausch J, Rushlow K, Montelaro RC, Issel C, Flaherty M, Perry S, Sellon D, Fuller F. Characterization of infectious molecular clones of equine infectious anaemia virus. The Journal of General Virology. 75: 425-9. PMID 8113766 DOI: 10.1099/0022-1317-75-2-425  0.386
1994 Ball JM, Henry NL, Montelaro RC, Newman MJ. A versatile synthetic peptide-based ELISA for identifying antibody epitopes. Journal of Immunological Methods. 171: 37-44. PMID 7513733 DOI: 10.1016/0022-1759(94)90226-7  0.417
1994 Grund CH, Lechman ER, Issel CJ, Montelaro RC, Rushlow KE. Lentivirus cross-reactive determinants present in the capsid protein of equine infectious anaemia virus Journal of General Virology. 75: 657-662. PMID 7510329 DOI: 10.1099/0022-1317-75-3-657  0.391
1993 Cunningham TP, Montelaro RC, Rushlow KE. Lentivirus envelope sequences and proviral genomes are stabilized in Escherichia coli when cloned in low-copy-number plasmid vectors. Gene. 124: 93-8. PMID 8382658 DOI: 10.1016/0378-1119(93)90766-V  0.318
1993 Miller MA, Mietzner TA, Cloyd MW, Robey WG, Montelaro RC. Identification of a calmodulin-binding and inhibitory peptide domain in the HIV-1 transmembrane glycoprotein Aids Research and Human Retroviruses. 9: 1057-1066. PMID 8312049 DOI: 10.1089/Aid.1993.9.1057  0.394
1993 DeVico AL, Issel CJ, Le Grice SFJ, Payne SL, Montelaro RC, Sarngadharan MG. High prevalence of serum antibodies to equine infectious anemia virus reverse transcriptase Aids Research and Human Retroviruses. 9: 7-11. PMID 7678974 DOI: 10.1089/Aid.1993.9.7  0.419
1992 Fontenot JD, Hoover EA, Elder JH, Montelaro RC. Evaluation of feline immunodeficiency virus and feline leukemia virus transmembrane peptides for serological diagnosis Journal of Clinical Microbiology. 30: 1885-1890. PMID 1629349 DOI: 10.1128/Jcm.30.7.1885-1890.1992  0.455
1992 Miller MA, Murphey-Corb M, Montelaro RC. Identification of broadly reactive continuous antigenic determinants of simian immunodeficiency virus glycoproteins Aids Research and Human Retroviruses. 8: 1153-1164. PMID 1380262 DOI: 10.1089/Aid.1992.8.1153  0.498
1992 Ball JM, Rushlow KE, Issel CJ, Montelaro RC. Detailed mapping of the antigenicity of the surface unit glycoprotein of equine infectious anemia virus by using synthetic peptide strategies Journal of Virology. 66: 732-742. PMID 1370556 DOI: 10.1128/Jvi.66.2.732-742.1992  0.513
1992 Schiltz RL, Shih DS, Rasty S, Montelaro RC, Rushlow KE. Equine infectious anemia virus gene expression: Characterization of the RNA splicing pattern and the protein products encoded by open reading frames S1 and S2 Journal of Virology. 66: 3455-3465. PMID 1316461 DOI: 10.1128/Jvi.66.6.3455-3465.1992  0.369
1992 Rushlow K, Peng XX, Montelaro RC, Shih DS. Expression of the protease gene of equine infectious anemia virus in Escherichia coli: Formation of the mature processed enzyme and specific cleavage of the gag precursor Virology. 188: 396-401. PMID 1314466 DOI: 10.1016/0042-6822(92)90773-I  0.339
1992 Elder JH, Lerner DL, Hasselkus-Light CS, Fontenot DJ, Hunter E, Luciw PA, Montelaro RC, Phillips TR. Distinct subsets of retroviruses encode dUTPase Journal of Virology. 66: 1791-1794. PMID 1310783 DOI: 10.1128/Jvi.66.3.1791-1794.1992  0.337
1992 Issel CJ, Horohov DW, Lea DF, Adams WV, Hagius SD, McManus JM, Allison AC, Montelaro RC. Efficacy of inactivated whole-virus and subunit vaccines in preventing infection and disease caused by equine infectious anemia virus. Journal of Virology. 66: 3398-3408. DOI: 10.1128/Jvi.66.6.3398-3408.1992  0.42
1991 Murphey-Corb M, Montelaro RC, Miller MA, West M, Martin LN, Davison-Fairburn B, Ohkawa S, Baskin GB, Zhang JY, Miller GB, Putneytt SD, Allison AC, Eppstein DA. Efficacy of SIV/DeltaB670 glycoprotein-enriched and glycoprotein-depleted subunit vaccines in protecting against infection and disease in rhesus monkeys Aids. 5: 655-662. PMID 1883540 DOI: 10.1097/00002030-199106000-00003  0.31
1991 Chong YH, Ball JM, Issel CJ, Montelaro RC, Rushlow KE. Analysis of equine humoral immune responses to the transmembrane envelope glycoprotein (gp45) of equine infectious anemia virus Journal of Virology. 65: 1013-1018. PMID 1846180 DOI: 10.1128/Jvi.65.2.1013-1018.1991  0.448
1991 DeVico A, Montelaro RC, Gallo RC, Sarngadharan MG. Purification and partial characterization of equine infectious anemia virus reverse transcriptase. Virology. 185: 387-94. PMID 1718086 DOI: 10.1016/0042-6822(91)90786-B  0.415
1991 Chong YH, Payne SL, Issel CJ, Montelaro RC, Rushlow KE. Characterization of the antigenic domains of the major core protein (p26) of equine infectious anemia virus Journal of Virology. 65: 1007-1012. PMID 1702839 DOI: 10.1128/Jvi.65.2.1007-1012.1991  0.447
1991 Miller MA, Garry RF, Jaynes JM, Montelaro RC. A structural correlation between lentivirus transmembrane proteins and natural cytolytic peptides Aids Research and Human Retroviruses. 7: 511-514+516. PMID 1657072  0.337
1991 Newman MJ, Issel CJ, Truax RE, Powell MD, Horohov DW, Montelaro RC. Transient suppression of equine immune responses by equine infectious anemia virus (EIAV) Virology. 184: 55-66. PMID 1651604 DOI: 10.1016/0042-6822(91)90821-R  0.429
1990 Montelaro R, Ball J, Rwambo P, Issel C. Antigenic variation during persistent lentivirus infections and its implications for vaccine development. Advances in Experimental Medicine and Biology. 251: 251-72. PMID 2481964 DOI: 10.1007/978-1-4757-2046-4_24  0.31
1990 Truax RE, Powell MD, Montelaro RC, Issel CJ, Newman MJ. Cryopreservation of equine mononuclear cells for immunological studies Veterinary Immunology and Immunopathology. 25: 139-153. PMID 2378055 DOI: 10.1016/0165-2427(90)90031-M  0.317
1990 Rwambo PM, Issel CJ, Adams WV, Hussain KA, Miller M, Montelaro RC. Equine infectious anemia virus (EIAV) Humoral responses of recipient ponies and antigenic variation during persistent infection Archives of Virology. 111: 199-212. PMID 2162160 DOI: 10.1007/Bf01311054  0.451
1990 Lo WCJ, Miller MA, Montelaro RC. Analysis of antibody reactivities in ELISA using protein blots as antigen substrates: S-ELISA Journal of Immunological Methods. 128: 17-25. PMID 2157766 DOI: 10.1016/0022-1759(90)90459-9  0.369
1990 Steinman R, Dombrowski J, O'Connor T, Montelaro RC, Tonelli Q, Lawrence K, Seymour C, Goodness J, Pedersen NC, Andersen PR. Biochemical and immunological characterization of the major structural proteins of feline immunodeficiency virus Journal of General Virology. 71: 701-706. PMID 2156003 DOI: 10.1099/0022-1317-71-3-701  0.337
1990 Rasty S, Dhruva BR, Louis Schiltz R, Shih DS, Issel CJ, Montelaro RC. Proviral DNA integration and transcriptional patterns of equine infectious anemia virus during persistent and cytopathic infections Journal of Virology. 64: 86-95. PMID 2152836 DOI: 10.1128/Jvi.64.1.86-95.1990  0.355
1990 Rwambo PM, Issel CJ, Hussain KA, Montelaro RC. In vitro isolation of a neutralization escape mutant of equine infectious anemia virus (EIAV) Archives of Virology. 111: 275-280. PMID 1693846 DOI: 10.1007/BF01311062  0.31
1989 Gallaher WR, Ball JM, Garry RF, Griffin MC, Montelaro RC. A general model for the transmembrane proteins of HIV and other retroviruses Aids Research and Human Retroviruses. 5: 431-440. PMID 2788443 DOI: 10.1089/Aid.1989.5.431  0.36
1989 Murphey-Corb M, Martin LN, Davison-Fairburn B, Montelaro RC, Miller M, West M, Ohkawa S, Baskin GB, Zhang JY, Putney SD, Allison AC, Eppstein DA. A formalin-inactivated whole SIV vaccine confers protection in macaques Science. 246: 1293-1297. PMID 2555923 DOI: 10.1126/Science.2555923  0.43
1989 Payne SL, Rushlow K, Dhruva BR, Issel CJ, Montelaro RC. Localization of conserved and variable antigenic domains of equine infectious anemia virus envelope glycoproteins using recombinant env-encoded protein fragments produced in Escherichia coli Virology. 172: 609-615. PMID 2552661 DOI: 10.1016/0042-6822(89)90203-1  0.408
1988 Zhang JY, Martin LN, Watson EA, Montelaro RC, West M, Epstein L, Murphey-Corb M. Simian immunodeficiency virus/delta-induced immunodeficiency disease in rhesus monkeys: relation of antibody response and antigenemia. The Journal of Infectious Diseases. 158: 1277-86. PMID 2848903 DOI: 10.1093/Infdis/158.6.1277  0.307
1988 Ball JM, Payne SL, Issel CJ, Montelaro RC. EIAV genomic organization: Further characterization by sequencing of purified glycoproteins and cDNA Virology. 165: 601-605. PMID 2841805 DOI: 10.1016/0042-6822(88)90605-8  0.32
1988 Hussain KA, Issel CJ, Rwambo PM, Arnizaut AB, Ball JM, Schnorr KL, Montelaro RC. Identification of gag precursor of equine infectious anaemia virus with monoclonal antibodies to the major viral core protein, p26. The Journal of General Virology. 69: 1719-24. PMID 2839604 DOI: 10.1099/0022-1317-69-7-1719  0.403
1988 Montelaro RC, Robey WG, West MD, Issel CJ, Fischinger PJ. Characterization of the serological cross-reactivity between glycoproteins of the human immunodeficiency virus and equine infectious anaemia virus Journal of General Virology. 69: 1711-1717. PMID 2839603 DOI: 10.1099/0022-1317-69-7-1711  0.435
1988 Clements JE, Gdovin SL, Montelaro RC, Narayan O. Antigenic variation in lentiviral diseases. Annual Review of Immunology. 6: 139-59. PMID 2838047 DOI: 10.1146/Annurev.Iy.06.040188.001035  0.426
1988 Ball JM, Rao VSV, Robey WG, Issel CJ, Montelaro RC. Lentivirus antigen purification and characterization: isolation of equine infectious anemia virus gag and env proteins in one step by reverse phase HPLC and application to human immunodeficiency virus glycoproteins Journal of Virological Methods. 19: 265-277. PMID 2836462 DOI: 10.1016/0166-0934(88)90021-3  0.412
1988 Hussain KA, Issel CJ, Schnorr KL, Rwambo PM, West M, Montelaro RC. Antigenic mapping of the envelope proteins of equine infectious anemia virus: identification of a neutralization domain and a conserved region on glycoprotein 90 Archives of Virology. 98: 213-224. PMID 2450529 DOI: 10.1007/BF01322170  0.335
1987 Payne SL, Salinovich O, Nauman SM, Issel CJ, Montelaro RC. Course and extent of variation of equine infectious anemia virus during parallel persistent infections Journal of Virology. 61: 1266-1270. PMID 3029423 DOI: 10.1128/Jvi.61.4.1266-1270.1987  0.437
1987 Payne SL, Fang FD, Liu CP, Dhruva BR, Rwambo P, Issel CJ, Montelaro RC. Antigenic variation and lentivirus persistence: Variations in envelope gene sequences during EIAV infection resemble changes reported for sequential isolates of HIV Virology. 161: 321-331. PMID 2825406 DOI: 10.1016/0042-6822(87)90124-3  0.36
1987 Hussain KA, Issel CJ, Schnorr KL, Rwambo PM, Montelaro RC. Antigenic analysis of equine infectious anemia virus (EIAV) variants by using monoclonal antibodies: Epitopes of glycoprotein gp90 of EIAV stimulate neutralizing antibodies Journal of Virology. 61: 2956-2961. PMID 2442410 DOI: 10.1128/Jvi.61.10.2956-2961.1987  0.437
1986 Salinovich O, Montelaro RC. Comparison of glycoproteins by two-dimensional mapping of glycosylated peptides Analytical Biochemistry. 157: 19-27. PMID 3021020 DOI: 10.1016/0003-2697(86)90190-9  0.333
1986 Murphey-Corb M, Martin LN, Rangan SR, Baskin GB, Gormus BJ, Wolf RH, Andes WA, West M, Montelaro RC. Isolation of an HTLV-III-related retrovirus from macaques with simian AIDS and its possible origin in asymptomatic mangabeys. Nature. 321: 435-7. PMID 3012358 DOI: 10.1038/321435A0  0.36
1986 Salinovich O, Payne SL, Montelaro RC, Hussain KA, Issel CJ, Schnorr KL. Rapid emergence of novel antigenic and genetic variants of equine infectious anemia virus during persistent infection Journal of Virology. 57: 71-80. PMID 3001367 DOI: 10.1128/Jvi.57.1.71-80.1986  0.461
1986 Rushlow K, Olsen K, Stiegler G, Payne SL, Montelaro RC, Issel CJ. Lentivirus genomic organization: The complete nucleotide sequence of the env gene region of equine infectious anemia virus Virology. 155: 309-321. PMID 2431539 DOI: 10.1016/0042-6822(86)90195-9  0.317
1986 Salinovich O, Montelaro RC. Reversible staining and peptide mapping of proteins transferred to nitrocellulose after separation by sodium dodecylsulfate-polyacrylamide gel electrophoresis Analytical Biochemistry. 156: 341-347. PMID 2429581 DOI: 10.1016/0003-2697(86)90263-0  0.365
1984 Montelaro RC, Parekh B, Orrego A, Issel CJ. Antigenic variation during persistent infection by equine infectious anemia virus, a retrovirus Journal of Biological Chemistry. 259: 10539-10544. PMID 6206055  0.371
1984 Montelaro RC, West M, Issel CJ. Antigenic reactivity of the major glycoprotein of equine infectious anemia virus, a retrovirus Virology. 136: 368-374. PMID 6205503 DOI: 10.1016/0042-6822(84)90173-9  0.489
1984 Payne S, Parekh B, Montelaro RC, Issel CJ. Genomic alterations associated with persistent infections by equine infectious anaemia virus, a retrovirus Journal of General Virology. 65: 1395-1399. PMID 6086822 DOI: 10.1099/0022-1317-65-8-1395  0.424
1983 Montelaro RC, West M, Issel CJ. Isolation of equine infectious anemia virus glycoproteins. Lectin affinity chromatography procedures for high avidity glycoproteins Journal of Virological Methods. 6: 337-346. PMID 6309879 DOI: 10.1016/0166-0934(83)90056-3  0.376
1982 Slosberg BN, Montelaro RC. A comparison of the mobilities and thermal transitions of retrovirus lipid envelopes and host cell plasma membranes by electron spin resonance spectroscopy Bba - Biomembranes. 689: 393-402. PMID 6288099 DOI: 10.1016/0005-2736(82)90274-7  0.308
1982 Montelaro RC, Lohrey N, Parekh B, Blakeney EW, Issel CJ. Isolation and comparative biochemical properties of the major internal polypeptides of equine infectious anemia virus Journal of Virology. 42: 1029-1038. PMID 6178843 DOI: 10.1128/Jvi.42.3.1029-1038.1982  0.339
1980 Parekh B, Issel CJ, Montelaro RC. Equine infectious anemia virus, a putative lentivirus, contains polypeptides analogous to prototype-C oncornaviruses Virology. 107: 520-525. PMID 6256947 DOI: 10.1016/0042-6822(80)90319-0  0.37
1978 Bolognesi DP, Montelaro RC, Frank H, Schafer W. Assembly of type C oncornaviruses: A model Science. 199: 183-186. PMID 202022 DOI: 10.1126/Science.202022  0.34
Show low-probability matches.